The reduced tumor growth in mice with pharmacologic blockade of C5aR or its genetic ablation in C5aR was caused by the increase in antitumor immune response, or synergistically inhibiting cancer cell growth by both cancer microenvironment and C5a-C5aR interaction in cancer cells? This evidence concerns the gene C5 and cancer.